Filed before 2025Filed 23 March 2017
eGenesis, Inc. raised $12.6M
eGenesis, Inc., a biotech company based in Cambridge, MA, raised $12.6M in a new equity round, according to a filing dated 23 March 2017.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 23 March 2017
- Round
- Equity round
- Amount sold
- $12.6M
- Offering size
- $38.2M
- Investors so far
- 12
- Based in
- Cambridge, MA
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 72% of the 1,645 tracked raises with an amount filed in 2017, and than 55% of the 152 in biotech.
eGenesis, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 27 Feb 2024 | New filing | $25.4M | Another raise |
| 10 Mar 2021 | New filing | $125M | Another raise |
| 14 Nov 2019 | New filing | $100M | Another raise |
| 23 Mar 2017 | New filing | $12.6M | This raise |
| 23 Aug 2016 | New filing | $2M | Another raise |
More with Biomatics Capital on the board
- Aledade, Inc.$260M
- Variant Bio, Inc.$105M
- Guide Therapeutics, Inc.$5.86M
- Editas Medicine, Inc.$120M
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.